ERBB2 and triple-negative breast carcinoma: HER2 discordance was observed according to the molecular subtype, in the Luminal A/B cohort (Kappa −0.044, −0.202–0.114) and in triple-negative breast cancer (Kappa 0.107, −0.247–0.461).